Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease

Blood

Volumn 116, Issue 18, 2010, Pages 3431-3434

  Strouse, John J ^a   Reller, Megan E ^a   Bundy, David G ^a   Amoako, Martha ^a   Cancio, Maria ^a   Han, Rachel N ^a   Valsamakis, Alexandra ^a   Casella, James F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BRONCHODILATING AGENT;

ACUTE CHEST SYNDROME; AGE DISTRIBUTION; ANTIMICROBIAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CHILD; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; HUMAN; INFLUENZA A (H1N1); INFLUENZA B; INTENSIVE CARE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NONHUMAN; PANDEMIC INFLUENZA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEASONAL INFLUENZA; SICKLE CELL ANEMIA;

EID: 78149340452     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-282194     Document Type: Article

References (19)

1. Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol. 2010;85(1):77-78.
2. Bundy DG, Strouse JJ, Casella JF, Miller MR. Burden of influenza-related hospitalizations among children with sickle cell disease. Pediatrics. 2010;125(2):234-243.
3. Glezen WP, Glezen LS, Alcorn R. Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. Am J Dis Child. 1983;137(11):1095-1097.
4. Souza AR, Braga JA, de Paiva TM, Loggetto SR, Azevedo RS, Weckx LY. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia. Vaccine. 2010;28(4):1117-1120.
5. Howard-Jones M, Randall L, Bailey-Squire B, Clayton J, Jackson N. An audit of immunisation status of sickle cell patients in Coventry, UK. J Clin Pathol. 2009;62(1):42-45.
6. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361(7):680-689.
7. Inusa B, Zuckerman M, Gadong N, et al. Pandemic influenza A (H1N1) virus infections in children with sickle cell disease. Blood;115(11):2329-2330.
8. van Tuijn CF, Nur E, van Beers EJ, Zaaijer HL, Biemond BJ. Acute chest syndrome in sickle cell disease due to the new influenza A (H1N1) virus infection. Am J Hematol. 2010;85(4):303-304.
9. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342(25):1855-1865.
10. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003-1032.
11. CDC protocol of realtime RTPCR for swine influenza a (H1N1). World Health Organization Web site. http://www.who.int/csr/resources/publications/swineflu/ CDCrealtimeRTPCRprotocol-20090428.pdf. Updated April 30, 2009. Accessed May 31, 2010.
12. Silvennoinen H, Peltola V, Lehtinen P, Vainionpaa R, Heikkinen T. Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J. 2009;28(5):372-375.
13. Infection. In: The Management of Sickle Cell Disease. 4th ed. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, Division of Blood Diseases and Resources; 2002. NIH publication 02-2117.
14. Crum-Cianflone NF, Blair PJ, Faix D, et al. Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. Clin Infect Dis. 2009;49(12):1801-1810.
15. O'Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ. 2009;182(1):39-44.
16. Zhu F-C, Wang H, Fang H-H, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med. 2009;361(25):2414-2423.
17. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009;361(25):2405-2413.
18. Clark TW, Pareek M, Hoschler K, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med. 2009;361(25):2424-2435.
19. Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Wkly Epidemiol Rec. 2010;85(10):81-92.